Zacks Research Analysts Boost Earnings Estimates for STERIS

STERIS plc (NYSE:STE) – Equities research analysts at Zacks Research boosted their Q1 2026 earnings estimates for STERIS in a research report issued on Tuesday, February 25th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will post earnings per share of $2.31 for the quarter, up from their previous estimate of $2.27. The consensus estimate for STERIS’s current full-year earnings is $9.08 per share. Zacks Research also issued estimates for STERIS’s Q2 2026 earnings at $2.36 EPS, Q1 2027 earnings at $2.62 EPS, Q2 2027 earnings at $2.69 EPS, Q3 2027 earnings at $2.81 EPS and FY2027 earnings at $10.72 EPS.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%.

Several other equities analysts have also commented on STE. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Piper Sandler upped their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Stephens reaffirmed an “overweight” rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Trading Down 1.4 %

Shares of STERIS stock opened at $219.89 on Thursday. The stock has a 50 day moving average of $214.45 and a 200 day moving average of $223.13. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market capitalization of $21.60 billion, a price-to-earnings ratio of 46.69 and a beta of 0.84. STERIS has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.04%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

Institutional Trading of STERIS

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of STERIS by 25.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock valued at $2,005,000 after purchasing an additional 1,713 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of STERIS by 32.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock worth $1,869,000 after acquiring an additional 1,904 shares in the last quarter. State of Alaska Department of Revenue grew its stake in shares of STERIS by 6.9% in the third quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock worth $2,778,000 after acquiring an additional 735 shares in the last quarter. First Trust Direct Indexing L.P. increased its position in shares of STERIS by 46.3% during the third quarter. First Trust Direct Indexing L.P. now owns 4,603 shares of the medical equipment provider’s stock worth $1,116,000 after acquiring an additional 1,456 shares during the period. Finally, Diversify Wealth Management LLC raised its stake in shares of STERIS by 7.8% in the third quarter. Diversify Wealth Management LLC now owns 4,222 shares of the medical equipment provider’s stock valued at $934,000 after acquiring an additional 304 shares in the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.